MERZ on the Move: Days After Ulthera Acquisition, Company Announces Plans for New Retinoid Therapy
Days after Ulthera acquisition, company announces plans to develop new Retinoid Therapy with Brickell Biotech.
Days after Ulthera acquisition, company announces plans to develop new Retinoid Therapy with Brickell Biotech.
Maximize your practice revenue with Jan Marini Skin Research's turnkey e-commerce solution. Increase patient engagement and boost sales by tapping into the booming skincare market.